By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – 3M and Northrop Grumman are receiving funding from the US Department of Health and Human Services to develop molecular diagnostics as countermeasures against biological weapons.

The awards are two of eight contracts that were announced by HHS' Biomedical Advanced Research and Development Authority earlier this week that total more than $100 million. 3M will receive $6 million, while Northrop Grumman will get $9.8 million under the program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.